???pagination.result.count???
???pagination.result.page???
1
Uricosuric targets of tranilast. , Mandal AK., Pharmacol Res Perspect. February 6, 2017; 5 (2): e00291.
Inhibition of cardiac two-pore-domain K+ (K2P) channels by the antiarrhythmic drug vernakalant--comparison with flecainide. , Seyler C., Eur J Pharmacol. February 5, 2014; 724 51-7.
Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channels. , Schmidt C., Eur J Pharmacol. December 5, 2013; 721 (1-3): 237-48.
TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation. , Seyler C., Br J Pharmacol. March 1, 2012; 165 (5): 1467-75.
Carvedilol targets human K2P 3.1 ( TASK1) K+ leak channels. , Staudacher K., Br J Pharmacol. July 1, 2011; 163 (5): 1099-110.
In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug-drug interaction with methotrexate. , Elsby R., Eur J Pharm Sci. May 18, 2011; 43 (1-2): 41-9.
The human cardiac K2P3.1 ( TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone. , Gierten J., Naunyn Schmiedebergs Arch Pharmacol. March 1, 2010; 381 (3): 261-70.
The selectivity, voltage-dependence and acid sensitivity of the tandem pore potassium channel TASK-1: contributions of the pore domains. , Yuill KH., Pflugers Arch. November 1, 2007; 455 (2): 333-48.
The flounder organic anion transporter fOat has sequence, function, and substrate specificity similarity to both mammalian Oat1 and Oat3. , Aslamkhan AG., Am J Physiol Regul Integr Comp Physiol. December 1, 2006; 291 (6): R1773-80.
Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. , Bakhiya A., Cell Physiol Biochem. January 1, 2003; 13 (5): 249-56.
Developmentally regulated expression of organic ion transporters NKT ( OAT1), OCT1, NLT ( OAT2), and Roct. , Pavlova A., Am J Physiol Renal Physiol. April 1, 2000; 278 (4): F635-43.